Search Results 921-930 of 16381 for monoclonal antibody
No history of severe allergic reactions to monoclonal antibodies. Female ... Hepatitis C as indicated by anti-hepatitis C antibody positivity; if a participant is ...
... monoclonal antibodies) prior to the index hospital admission. Previous administration of S aureus vaccine or S aureus/Candida vaccine. Antibiotic therapy ...
Clinical use of monoclonal antibody disease-modifying therapies for multiple sclerosis. https://www.uptodate.com/contents/search. Accessed June 19, 2024 ...
... monoclonal antibody (mAb) targeting MET (such as onartuzumab [MetMAb]); The subject has received radionuclide treatment =< 6 weeks of the first dose of study ...
... monoclonal antibodies and glucocorticoids. Patients must be at least 90 days since autologous stem cell transplant, if performed. Patients must have ...
Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or who has not recovered (i.e., ≤ Grade 1 or at baseline) from ...
Participation eligibility · Prior mogamulizumab. · Any systemic therapy, including monoclonal antibody within 28 days or 5 half-lives (whichever is shorter) of ...
... antibody at any point prior to registration -CD20-targeted monoclonal antibody (e.g., rituximab, obinutuzumab or biosimilars) =< 4 weeks prior to ...
- Other monoclonal antibodies, antibody-drug conjugates, radioimmunoconjugates, or experimental therapies: ≤4 weeks (≤3 weeks with documented disease ...
Services · Mass cytometry- CyTOF using the Helios instrument. · Custom heavy metal conjugation of antibodies through collaboration with the Antibody Hybridoma ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact 2X.